Cookie Policy

A full description of our cookie policy can be found here.

Essential (Required)

Cookies that the site cannot function without. This includes cookies for access to secure areas and CSRF protection. Please note that Craft's default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.

Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionName config setting. This cookie will expire as soon as the session expires.
Provider: biocatalysts.com
Expiry: Session

Name: *_identity
Description: When you log into the control panel, you’ll get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: biocatalysts.com
Expiry: Persistent

Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: biocatalysts.com
Expiry: Persistent

Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: biocatalysts.com
Expiry: Session

BRAINBiocatalysts Partners with IMCD to Expand Enzyme-Based Dietary Solutions Across Europe

Published 13 October 2025

Home/ Media & Resources/ BRAINBiocatalysts Partners with IMCD to Expand Enzyme-Based Dietary Solutions Across Europe

BRAINBiocatalysts, incorporated as Biocatalysts Ltd, has teamed up with IMCD to bring cutting-edge enzyme solutions to the European dietary supplement market. Through this exclusive distribution agreement, IMCD will help expand access to BRAINBiocatalysts’ innovative enzyme portfolio across key regions.

This collaboration marks a significant step in further accelerating the global reach of BRAINBiocatalysts' enzyme technologies. Leveraging IMCD’s strong technical expertise, market access, and established relationships within the health and nutrition space, the partnership will enhance availability and support for dietary supplement manufacturers seeking highly effective, and customisable enzyme solutions.

“We are excited to partner with IMCD, a trusted and experienced distributor in the health and nutrition industry,” said Daren Bryce, VP at BRAINBiocatalysts Life Science Solutions.

The agreement will benefit dietary supplement customers by combining BRAINBiocatalysts’ scientific expertise in enzyme development and biomanufacturing with IMCD’s deep market insight and customer support capabilities. The partnership will focus on solutions for digestion, immunity, metabolic health, and other targeted health areas.

“

This agreement ensures that our unique enzyme technologies can more efficiently reach formulators and manufacturers, enabling the development of innovative, science-backed supplements for growing consumer health demands.

— Daren Bryce, VP BRAINBiocatalysts Life Science Solutions